TRU-SENTIMENT ยท DeltaNeutral
ACAD Trading Analysis - 09/23/2026 03:45 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $25.21. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $517,460 vs put $5,650. RSI 19.8.
- Symbol
- ACAD
- Price
- $25.21
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-23 15:45:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $517,460
- Put dollar volume: $5,650
The options flow suggests a bullish sentiment, with a significant imbalance between call and put dollar volumes.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 11.84 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 6.96 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
๐ Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment (Source: Company Press Release)
- Analysts raise price targets for ACAD following strong quarterly earnings (Source: Bloomberg)
- ACAD's drug pipeline shows promising results in clinical trials (Source: Reuters)
These headlines suggest a positive outlook for ACAD, with potential catalysts for growth in the near term.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 11.84
- Price-to-Book: 6.96
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
ACAD's fundamentals indicate a strong revenue base and healthy profitability metrics. The P/E ratio suggests a relatively fair valuation.
Current Market Position:
Current price: $25.25
Recent price action: The stock has been trending downward, with a recent low of $24.93.
Key support and resistance levels:
| Level | Price |
|---|---|
| Support | $24.93 |
| Resistance | $27.82 |
Technical Analysis:
Technical Indicators
SMA trends: The 50-day SMA ($27.62) is above the current price ($25.25), indicating a downtrend.
RSI: The RSI (14) is 19.79, indicating oversold conditions.
MACD: The MACD is -0.53, indicating a bearish signal.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $517,460
- Put dollar volume: $5,650
The options flow suggests a bullish sentiment, with a significant imbalance between call and put dollar volumes.
Key Price Levels (observational only):
| Level | Price |
|---|---|
| Support | $24.93 |
| Resistance | $27.62 |
25-Day Price Forecast:
ACAD is projected for $23.50 to $26.50
Rationale: Based on current SMA trends, RSI momentum, and MACD signals, the stock price may fluctuate within a narrow range.
Defined Risk Strategy Recommendations:
Based on the price forecast, consider the following strategies:
- Bull Call Spread: Buy $25.00 call, sell $27.00 call (expiration: 2026-10-16)
- Bear Put Spread: Buy $24.00 put, sell $22.00 put (expiration: 2026-10-16)
- Iron Condor: Buy $24.00 put, sell $22.00 put, buy $27.00 call, sell $29.00 call (expiration: 2026-10-16)
Risk Factors:
- Technical warning signs: RSI oversold conditions
- Sentiment divergences: Bullish options flow vs bearish technical trends
- Volatility: ATR 14 is 0.84
Summary & Conviction Level:
Overall bias: Bearish
Conviction level: Medium
One-line trade idea: Consider defined risk strategies to capitalize on potential price movements.
View ACAD Options Chain